Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis*

Author: Sheng Duh Mei   Dial Ellison   Choueiri Toni K.   Fournier Andree-Anne   Antras Lucia   Rodermund Douglas   Neary Maureen P.   Oh William K.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.25, Iss.8, 2009-08, pp. : 2081-2090

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content